Patent: 9,359,434
✉ Email this page to a colleague
Summary for Patent: 9,359,434
| Title: | Cell culture methods to reduce acidic species |
| Abstract: | The instant invention relates to the field of protein production and purification, and in particular to compositions and processes for controlling the amount of acidic species expressed by host cells, as well as to compositions and processes for controlling the amount of acidic species present in purified preparations. |
| Inventor(s): | Subramanian; Kartik (Northborough, MA), Zeng; Xiaobei (Carolina, PR), Dong; Diane D. (Shrewsbury, MA), Lim; Wen Chung (Worcester, MA), Gifford; Kathreen A. (Marlborough, MA), Chumsae; Christopher (North Andover, MA) |
| Assignee: | AbbVie, Inc. (North Chicago, IL) |
| Application Number: | 14/842,933 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,359,434 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,359,434
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | December 31, 2002 | ⤷ Start Trial | 2035-09-02 |
| Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | February 21, 2008 | ⤷ Start Trial | 2035-09-02 |
| Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | April 24, 2013 | ⤷ Start Trial | 2035-09-02 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 9,359,434
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Argentina | 095268 | ⤷ Start Trial |
| Australia | 2013381687 | ⤷ Start Trial |
| Australia | 2013381759 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
